...Continued

Arteris Announces Financial Results for the First Quarter 2024 and Second Quarter and Full Year 2024 Guidance

Retrieved on: 
Thursday, May 2, 2024
IP, TTM, Safety, AI, SOC, ...Continued, Partnership, Conference, AI accelerator, ACV, RPO, Synthetic media, Electronics, Mercedes-Benz, Communication, AIP, Consumer electronics, Generative, Arm, GAAP, Arteris, Video game

CAMPBELL, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced financial results for the first quarter ended March 31, 2024 and provided second quarter and full year 2024 guidance.

Key Points: 
  • CAMPBELL, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced financial results for the first quarter ended March 31, 2024 and provided second quarter and full year 2024 guidance.
  • “Nearly half of our license deals this quarter facilitated AI/ML design starts, showcasing the significance of AI for our clients.
  • Additional information on Arteris’ historic reported results, including a reconciliation of these Non-GAAP financial measures to their most comparable GAAP measures, is included in the financial tables below.
  • Second Quarter and Full Year 2024 Guidance:

Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing

Retrieved on: 
Tuesday, April 23, 2024
Sequence, Small RNA, RNA editing, Potency, Durability, Health, ...Continued, RNA, MD, Doctor of Philosophy, Weight loss, IND, CNS, Obesity, Oligonucleotide, GSK, Patient, Medicinal chemistry, MBA, Liu Wei, Clinical trial, Pharmaceutical industry

CAMBRIDGE, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today provided an update on its best-in-class small interfering RNA (siRNA) and RNA editing platform capabilities.

Key Points: 
  • As part of Wave’s ongoing collaboration with GSK, GSK has selected its first two programs to advance to development candidates following achievement of target validation.
  • GSK will provide an aggregate initiation payment of $12 million to Wave for these two oligonucleotide programs.
  • Under the agreement, GSK can advance up to eight programs leveraging Wave’s PRISM™ platform and multiple RNA-targeting modalities (RNA editing, splicing, siRNA, and antisense) with target validation work ongoing across multiple therapy areas.
  • Beyond these programs, our collaboration is focusing on all Wave modalities, including RNA editing.

Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Wednesday, March 27, 2024
Financial management, Patient, Ageing, ...Continued, OI, Epidemiology, EMA, Pediatrics, Osteogenesis imperfecta, FDA, Lithium

LONDON, March 27, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced its financial results for the full year ended December 31, 2023, and provided an update on recent corporate highlights.

Key Points: 
  • “We reached a number of important milestones in 2023, which have set the stage for a potentially transformative 2024,” said Dr. Denise Scots-Knight, Chief Executive Officer of Mereo.
  • Cosmic was initiated in the second half of 2023 and is anticipated to be fully enrolled in the first half of 2024.
  • Accordingly, the full year 2023 financial results are presented in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and in U.S. dollars.
  • Total ADS equivalents as of December 31, 2023 were 140,243,417, with each ADS representing five ordinary shares of the Company.

Blend Announces Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Friday, March 15, 2024
Professional Services, Technology, Software, Finance, Fintech, Internet, Banking, Growth, Retail banking, ...Continued, BLND, Mortgage Bankers Association, GAAP, Citizens Bank, Total, Fannie Mae, Bank

Blend Labs, Inc. (NYSE:BLND), a leader in cloud banking software, today announced its fourth quarter and full year 2023 financial results.

Key Points: 
  • Blend Labs, Inc. (NYSE:BLND), a leader in cloud banking software, today announced its fourth quarter and full year 2023 financial results.
  • “Despite a challenging market environment, Blend has achieved substantial progress on our three strategic priorities over the course of 2023,” said Nima Ghamsari, Head of Blend.
  • Total company revenue in 2023 was $156.8 million, composed of Blend Platform segment revenue of $109.5 million and Title segment revenue of $47.3 million.
  • Non-GAAP Blend Platform segment gross profit was $77.4 million in 2023, up from $76.3 million in 2022.

Across Europe Retail Investor Voting Activity is Growing, According to New Broadridge Whitepaper

Retrieved on: 
Wednesday, March 27, 2024
Research, Capital Markets Union, Communication, Broadridge Financial Solutions, SRD, ESG, SRD II, ...Continued, App Store (iOS/iPadOS), Fintech, CMU, Digital transformation, Security (finance)

NEW YORK and LONDON, March 27, 2024 /PRNewswire/ -- Global Fintech leader Broadridge Financial Solutions, Inc. (NYSE:BR) today announced its latest whitepaper on the trends driving the proxy voting and corporate governance activities of retail investors throughout Europe.

Key Points: 
  • NEW YORK and LONDON, March 27, 2024 /PRNewswire/ -- Global Fintech leader Broadridge Financial Solutions, Inc. (NYSE:BR) today announced its latest whitepaper on the trends driving the proxy voting and corporate governance activities of retail investors throughout Europe.
  • "The evolving regulatory framework in Europe to support both ESG and shareholder voting, both for equities and funds will more than likely encourage even higher retail activity in the longer term," said Demi Derem, General Manager of International Corporate Governance, Digital Transformation and Market Innovation at Broadridge.
  • "Working with Broadridge and their insights and data on corporate governance has enabled us to delve deeper into the underlying trends driving increased activity from retail investors."
  • Broadridge works with financial intermediary firms internationally to provide them with a seamless and white-labelled proxy voting service that empowers their retail investor clients and drives higher levels of engagement.

Boost Your Salon Business with GK Hair - Unveiling the Exclusive Benefits for Stylists

Retrieved on: 
Thursday, February 8, 2024
Online, Business, Growth, Education, GK, Affiliate marketing, ...Continued, Beauty salon

Online Classes for Continued Education: GK Hair is committed to the ongoing education of stylists.

Key Points: 
  • Online Classes for Continued Education: GK Hair is committed to the ongoing education of stylists.
  • Our online classes are crafted to help stylists stay ahead of the curve in the ever-evolving world of hair care and styling.
  • Affiliate Program – Grow with GK Hair: The GK Hair Affiliate Program presents an extraordinary opportunity for stylists to grow alongside our brand.
  • We invite stylists and salon owners to explore these exclusive benefits and join the GK Hair family.

UNIFI®, Makers of REPREVE®, Announces Second Quarter Fiscal 2024 Results

Retrieved on: 
Wednesday, January 31, 2024
Fashion, Retail, Chemicals, Plastics, Environment, Manufacturing, Other Manufacturing, Textiles, Ingle, EPS, Growth, GAAP, Calendar, Debt, Segment, Capital, Capital expenditure, UFI, Adjustment, ...Continued, Operating cost, Eastern Time Zone, Video game

Unifi, Inc. (NYSE: UFI) (together with its consolidated subsidiaries, “UNIFI”), makers of REPREVE and one of the world’s leading innovators in recycled and synthetic yarns, today released operating results for the second fiscal quarter ended December 31, 2023.

Key Points: 
  • Unifi, Inc. (NYSE: UFI) (together with its consolidated subsidiaries, “UNIFI”), makers of REPREVE and one of the world’s leading innovators in recycled and synthetic yarns, today released operating results for the second fiscal quarter ended December 31, 2023.
  • Net sales were $136.9 million, an increase of 0.5% from the second quarter of fiscal 2023, driven by higher sales volumes that were muted by lower pricing in response to lower raw material costs.
  • Adjusted EBITDA, which also excludes $5.1 million of restructuring costs, was ($5.5) million, compared to ($13.0) million for the second quarter of fiscal 2023.
  • Additionally, UNIFI expects sequential improvement from the third quarter to the fourth quarter of fiscal 2024.

LEONOVUS ANNOUNCES SALE OF ASSETS AND DEBT SETTLEMENT

Retrieved on: 
Wednesday, January 31, 2024
News, CDN, CRL, Transaction, LTV, Policy, Privacy, Access control, ZTNA, Software, The Insider, Internet of things, Layer, Indian stock exchange, Chair, ...Continued, Debt, Acquisition, Disposition, NEX, Legislation, Deposit, Debt settlement, Warrant, LOI, Documentation, TSX Venture Exchange, IEEE 802.1AE, Minority, Person, Patent, Creditor, Sale, Communication, Bank

The Transaction is subject to the requirement that the Company and CRL enter into a definitive purchase and sale agreement (the "Definitive Agreement").

Key Points: 
  • The Transaction is subject to the requirement that the Company and CRL enter into a definitive purchase and sale agreement (the "Definitive Agreement").
  • "Our historical quarterly Management Discussion and Analysis noted the Company's need to find a strategic solution such as merger, acquisition, or sale of assets.
  • Related party involvement in the Debt Settlement constitutes a "related party transaction".
  • The Company expects to complete the debt settlement following completion of the Transaction.

Ring Energy Announces Issuance of 2023 Sustainability Report

Retrieved on: 
Thursday, December 28, 2023
Greenhouse gas, Culture, ...Continued, Sustainable Development Goals, Acquisition, GHG, Health, ESG, REI, Disclosure, United, Social, Task force, Feedback, CBP, TARGET, Safety, United Nations, Renewable energy

THE WOODLANDS, Texas, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced that it has issued its 2023 Sustainability Report (the “2023 Report”), which is available on the Company’s website at www.ringenergy.com under the “Sustainability” tab.

Key Points: 
  • THE WOODLANDS, Texas, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced that it has issued its 2023 Sustainability Report (the “2023 Report”), which is available on the Company’s website at www.ringenergy.com under the “Sustainability” tab.
  • The report provides updated and comprehensive information about Ring’s Environmental, Social and Governance (“ESG”) initiatives and related key performance indicators.
  • During 2022 and into 2023, the Company has executed a number of its targeted ESG initiatives, and these projects are discussed in the 2023 Report.
  • We are confident our 2023 Report showcases our progress on these important fronts.”

In Vitro Diagnostic (IVD) Trends and Market Report 2023 - New Opportunities in Multiplex Testing, Next-Generation Sequencing, Artificial Intelligence and Disruptive Technologies - ResearchAndMarkets.com

Retrieved on: 
Friday, December 22, 2023
Biotechnology, Science, Health, Research, Immunochemistry, Mass spectrometry, NGS, Medicine, ...Continued, COVID-19, Fad, COVID-19 testing, IVD

The "In Vitro Diagnostic (IVD) Trends and Market Update: 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "In Vitro Diagnostic (IVD) Trends and Market Update: 2023" report has been added to ResearchAndMarkets.com's offering.
  • In vitro diagnostic (IVD) testing is getting back to regular business and continues to be a driving force in the practice of medicine.
  • Trends highlighted throughout Q3 2023 include:
    In IVD Trends and Market Update Report, you'll discover the following:
    What's Driving Growth in the IVD Market in Q3 and the last half of 2023?
  • What Product Trends and New Developments Will Shape the IVD Market in the last half of 2023?